Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Roberta Carosio"'
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Targeting the Immune Checkpoint molecules (ICs; CTLA-4, PD-1, PD-L1/2, and others) which provide inhibitory signals to T cells, dramatically improves survival in hard-to-treat tumors. The establishment of an immunosuppressive environment prevents end
Externí odkaz:
https://doaj.org/article/2b380e2e926749ef9dd90c42350f451d
Autor:
Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/17dcc47c50bb49ec873347c34fa5d085
Autor:
Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Ipilimumab (IPI) blocks CTLA-4 immune checkpoint resulting in T cell activation and enhanced antitumor immunity. IPI improves overall survival (OS) in 22% of patients with metastatic melanoma (MM). We investigated the association of CTLA-4 single nuc
Externí odkaz:
https://doaj.org/article/b02add3271194d79888e42ef5158e77a
Autor:
Mirco Ponzoni, Vito Pistoia, Domenico Ribatti, Beatrice Nico, Michele Cilli, Federica Piccardi, Luis J.V. Galietta, Monica Loi, Annalisa Pezzolo, Chiara Brignole, Danilo Marimpietri, Fabio Pastorino, Roberta Carosio, Daniela Di Paolo, Gabriella Pagnan
Supplementary Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d148e049274ca37297071726ad7739
https://doi.org/10.1158/1078-0432.22440579
https://doi.org/10.1158/1078-0432.22440579
Autor:
Mirco Ponzoni, Vito Pistoia, Domenico Ribatti, Beatrice Nico, Michele Cilli, Federica Piccardi, Luis J.V. Galietta, Monica Loi, Annalisa Pezzolo, Chiara Brignole, Danilo Marimpietri, Fabio Pastorino, Roberta Carosio, Daniela Di Paolo, Gabriella Pagnan
Purpose: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblastoma. Bortezomib has been shown to induce synergistic activity when combined with other antineoplastic agents. Here we have investigated the antitumor act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b323b035a19d2853149a09e0fe2532b
https://doi.org/10.1158/1078-0432.c.6517884.v1
https://doi.org/10.1158/1078-0432.c.6517884.v1
Autor:
Beatrice Dozin, Luca Mastracci, Maria Pia Pistillo, Francesco Spagnolo, Andrea Boutros, Marina Gualco, Vincenzo Fontana, Roberta Carosio, Enrica Teresa Tanda, Sandra Salvi, Paola Queirolo, Barbara Banelli, Massimo Romani, Anna Morabito, Alessandro Poggi, Federica Grillo
Publikováno v:
Cancer Immunology, Immunotherapy. 69:653-662
Immune checkpoint inhibitors, including ipilimumab (IPI), achieve a clinical benefit in a small proportion of melanoma patients highlighting the need to investigate predictive biomarkers. In this study, we characterized tumor infiltrating lymphocytes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::059b12cb6c4fa10aedde0d11faa46edd
https://doi.org/10.1007/s00262-020-02494-y
https://doi.org/10.1007/s00262-020-02494-y
Autor:
Ugo Giannoni, Maria Pia Pistillo, Vincenzo Fontana, Antonella Vigani, Marika Tonarelli, Paolo Dessanti, Giovanni Berisso, Paola Ferro, Cristiana Rossi, Pier Aldo Canessa, Roberta Carosio, Silvio Roncella, Maria Cristiana Franceschini
Publikováno v:
Anticancer Research. 39:5219-5223
AIM This study evaluated the prognostic value of soluble mesothelin-related protein (SMRP) levels in pleural effusions (PE) from patients with pleural mesothelioma (MPM). PATIENTS AND METHODS SMRP level in PE was tested using an enzyme-linked immunos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25a43d3c132b9f39116f9982c498e14
https://doi.org/10.21873/anticanres.13719
https://doi.org/10.21873/anticanres.13719
Autor:
Maria Cristiana Franceschini, Giovanni Berisso, Paola Ferro, Paolo Dessanti, Pier Aldo Canessa, Antonella Vigani, Roberta Carosio, Maria Pia Pistillo, Vincenzo Fontana, Marika Tonarelli, Ugo Giannoni, Silvio Roncella
Publikováno v:
Oncol Lett
Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor survival rates. Therefore, it is essential to have effective biological markers predicting the course of the disease and prognosis. The aim of the present study was to highlight th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3564e2cb0b477aa6f859380ef3da0806
https://doi.org/10.3892/ol.2020.12389
https://doi.org/10.3892/ol.2020.12389
Autor:
Roberta Carosio, Antonella Vigani, Luca Mastracci, Paolo Dessanti, Paola Ferro, Barbara Banelli, Pier Aldo Canessa, Anna Morabito, Maria Pia Pistillo, Vincenzo Fontana, Federica Grillo, Silvio Roncella, Ulrich Pfeffer, Alessandro Poggi
Publikováno v:
Journal of cancer research and clinical oncology. 147(2)
Programmed death-ligand 1 (PD-L1) protein plays a central role in the antitumor immune response, and appears to be a predictor of prognosis and efficacy for PD-L1 and programmed death 1 (PD-1) blockade therapy. The immunoregulatory role and prognosti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c29cfc77b78922295bfc8e86ba996e
https://pubmed.ncbi.nlm.nih.gov/33216211
https://pubmed.ncbi.nlm.nih.gov/33216211
Autor:
Stefania Tommasi, Maria Pia Pistillo, Beatrice Dozin, Vincenzo Fontana, Paolo Fava, Massimo Guidoboni, Massimo Romani, Barbara Banelli, Italian Melanoma Intergroup, Pier Francesco Ferrucci, Gabriele Madonna, Michele Guida, Francesco Spagnolo, Chiara Martinoli, Federica De Galitiis, Laura Ghilardi, Barbara Merelli, Paolo Marchetti, Diego Ferone, Roberta Carosio, Emilia Cocorocchio, Paola Queirolo, Anna Morabito, Ester Simeone, Paolo A. Ascierto, Gian Carlo Antonini Cappellini, Simona Osella-Abate
Publikováno v:
European Journal of Cancer. 97:59-61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7e2ba3ae943c555f333c5df2062c59
https://doi.org/10.1016/j.ejca.2018.04.005
https://doi.org/10.1016/j.ejca.2018.04.005